Goldman Sachs downgraded Regenxbio (RGNX) to Neutral from Buy with a price target of $14, down from $38. The firm has questions over the ...

Goldman Sachs downgraded Dynavax (DVAX) to Sell from Neutral with a price target of $12, down from $15. The evolving competitive landscape in ...

DeepSeek has enabled investors to see the potential of Chinese technology stocks. Since February, several foreign-funded ...

Goldman Sachs, Wells Fargo, Citigroup, Bank of America, Morgan Stanley and JPMorgan - which left the alliance over the last ...

Employees’ privileged access to its own funds show a widening compensation gap on Wall Street. Marc Rubinstein is a former ...

President Donald Trump signed an executive order rolling back enforcement of a law that bars US companies from bribing ...

Global power consumption in data centers will more than double by 2030 due to AI, analysts estimate. There will also be an ...

Illustration of the Direct Line Group logo and a rising stock graph. Banks, lawyers and advisers are set to share a £120m ...

Finding stocks with the potential to double in just three years is no easy feat, even in this bull market. Plenty of ...

We recently compiled a list of the 11 Best Stocks To Invest In For Grandchildren. In this article, we are going to take a ...

A Redditor expressed his disappointment over a formal employment offer that he received after a three-month wait, and that ...